Two cases of disseminated mucormycosis in patients with hematological malignancies and literature review

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 17, Issue 12, 1998, Pages 859-863

  Cuvelier, I ^a   Vogelaers, D ^a   Peleman, R ^a   Benoit, D ^a   Van Marck, V ^a   Offner, F ^a   Vandewoude, K ^a   Colardyn, F ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEFTAZIDIME; COTRIMOXAZOLE; CYTOMEGALOVIRUS ANTIBODY; ERYTHROMYCIN; FLUCONAZOLE; NETILMICIN;

ADULT; ARTICLE; AUTOPSY; BIOPSY; CASE REPORT; DEBRIDEMENT; DISEASE COURSE; EARLY DIAGNOSIS; FATALITY; FEMALE; FEVER; HEMATOLOGIC DISEASE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LUNG INFILTRATE; MALE; MALIGNANT NEOPLASTIC DISEASE; MUCORMYCOSIS; MYELOID LEUKEMIA; PRIORITY JOURNAL; SURVIVAL; T CELL LEUKEMIA;

ADULT; FATAL OUTCOME; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MUCORMYCOSIS;

EID: 0032407029     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050207     Document Type: Article

References (34)

1. 1. Sugar AM: Agents of mucormycosis and related species. In: Mandell GL, Bennett JE, Dolin R (eds): Principles and practice of infectious diseases. Churchill Livingstone, New York (1995) pp 2311-2321
2. 2. Benbow EW, Stoddart RW: Systemic zygomycosis. Postgraduate Medical Journal (1986) 62:985-996
3. 3. Noble WC, Clayton YM: Fungi in the air of hospital wards. Journal of General Microbiology (1963) 32:397
4. 4. Meyer RD, Rosen P, Armstrong D: Phycomycosis complicating leukaemia and lymphoma. Annals of Internal Medicine (1972) 77:871-879
5. 5. Lehrer RI, Howard DH, Sypherd PS, Edwards JE, Segal GP, Winston DJ: Mucormycosis. Annals of Internal Medicine (1980) 93:93-108
6. 6. Boelaert JR, Roost GFV, Vergauwe PL, Verbanck JJ, Vroey CD, Segaert MF: The role of deferoxamine in dialysis-associated mucormycosis: report of three cases and review of the literature. Clinical Nephrology (1988) 29:261-266
7. 7. Wirth F, Perry R, Eskenazi A, Schwalbe R, Kao G: Cutaneous mucormycosis with subsequent visceral dissemination in a child with neutropenia: a case report of the pediatric literature. Journal of the American Academy of Dermatology (1996) 35:336-341
8. 8. Melnick JZ, Latimer J, Lee EL, Henrich WL: Systemic mucormycosis complicating acute renal failure: case report and review of the literature. Renal Failure (1995) 17:619-627
9. 9. Walsh TJ, Hiemenz J, Pizzo PA: Evolving risk factors for invasive fungal infections-all neutropenic patients are not the same. Clinical Infectious Diseases (1994) 18:793-798
10. 10. Adam RD, Hunter GH, DiTomasso J, Comerci G: Mucormycosis: emerging prominence of cutaneous infections. Clinical Infectious Diseases (1994) 19:67-76
11. 11. Agger WA, Maki DG: Mucormycosis: a complication of critical care. Archives of Internal Medicine (1978) 138:925-927
12. 12. Agh F, Spanik S, Gyarfas J, Horvath J, Krcmery V: Three fatal cases of disseminated mucormycosis associated with respiratory distress syndrome and shock in patients with hematologic malignancies. Infection (1992) 64:112
13. 13. Chandler FW, Watts JC: Zygomycosis. In: Connor DH, Chandler FW, Schwartz DA, Manz HJ, Lack (eds): Pathology of infectious diseases. Appleton and Lange, Stanford (1997) pp 1113-1119
14. 14. Waldorf AR, Levitz SM, Diamond RD: In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. Journal of Infectious Diseases (1984) 150:752-760
15. 15. Levitz SM, Selsted ME, Ganz T, Lehrer RI, Diamond RD: In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil and cationic peptides and bronchoalveolar macrophages. Journal of Infectious Diseases (1986) 154:483-489
16. 16. Sugar AM: Mucormycosis. Clinical Infectious Diseases (1992) 14 (Supplement 1):126-129
17. 17. Parfrey NA: Improved diagnosis and prognosis of mucormycosis, a clinicopathologic study of 33 cases. Medicine (1986) 65:113-123
18. 18. Kline MW: Mucormycosis in children: review of the literature and report of cases. Pediatric Infectious Disease Journal (1985) 4:672-676
19. 19. Ingram CW, Sennesh J, Cooper JN, Perfect JR: Disseminated zygomycosis: report of four cases and review. Reviews of Infectious Diseases (1989) 11:741-754
20. 20. Kirkpatrick CH: Chronic mucocutaneous candidiasis. In: Bodey GP (ed): Candidiasis: pathogenesis, diagnosis and treatment. Raven Press, New York (1993) pp 167-184
21. 21. Loughran TP: Clonal diseases of large granular lymphocytes. Blood (1993) 82:1-14
22. 22. Wheat LJ: Mucormycosis. In: Rubin PH, Young LS (eds): Clinical approach to infection in the compromised host. Plenum, New York (1994) pp 222-223
23. 23. Chandler FW, Watts JC: Mucormycosis. In: Dail DH, Hammer SP (eds): Pulmonary Pathology. Springer Verlag, New York (1994) pp 392-395
24. 24. Armstrong D: Problems in management of opportunistic fungal diseases. Reviews of Infectious Diseases (1989) 11 (Supplement 7):1591-1599
25. 25. Walsh TJ, Hiemenz JW, Seibel NL, Perfect JR, Horwith G, Lee L, Silber JL, DiNubile MJ, Peboli A, Bow E, Lister J, Anaissie EJ: Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clinical Infectious Diseases (1998) 26:1383-1396
26. 26. Humphreys JM, Stringer RE, Hart A, Edwards SW: Effect of cytotoxic drugs on mature neutrophil function in the presence and absence of granulocyte-macrophage colony-stimulating factor. British Journal of Haematology (1993) 84:316-321
27. 27. Sahin B, Paydas S, Cosar E, Bicakci K, Hazar B: Role of granulocyte colony-stimulating factor in the treatment of mucormycosis. European Journal of Clinical Microbiology & Infectious Diseases (1996) 15:866-869
28. 28. Gonzalez CE, Couriel DR, Walsh TJ: Disseminated zygomycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor. Clinical Infectious Diseases (1997) 24:192-196
29. 29. St-Germain G, Ishak M, Tremblay C, Claveau S: Infection due to Rhizomucor pusillus: report of four cases in patients with leukemia and review. Clinical Infectious Diseases (1993) 16:640-645
30. 30. Ranguel-Guerra RA, Martinez HR, Saenz C, Bosques-Pallida F, Estrada-Bellmann I: Rhinocerebral and systemic mucormycosis. Clinical experience with 36 cases. Journal of the Neurological Sciences (1996) 143:19-30
31. 31. Celgow L, Sacks AJ, Cohn RJ: Disseminated mucormycosis: report of a succesfully treated immunosuppressed child with clinical, radiographic and pathological findings. Pediatric Radiology (1996) 23:131-133
32. 32. Szelenyi H, Foss HD, Kreuser ED, Knauf W, Thiel E: Fatal mucor pneumonia after treatment with 2-chlorodeoxyadenosine for non-Hodgkin's lymphoma. Annals of Hematology (1996) 73:145-147
33. 33. Kontonyianis DP, Vartivarian S, Anaissie EJ, Samonis G, Bodey GP, Rinaldi M: Infections due to Cunninghamella bertholletiae in patients with cancer: report of three cases and review. Clinical Infectious Diseases (1994) 18:925-928
34. 34. Servero LC, Job F, Mattos TC: Systemic zygomycosis: nosocomial infection by Rhizomucor pusillus. Mycopathologica (1991) 113:79-80